• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Awake prone positioning may not offer clinical benefits among patients hospitalized with COVID-19-associated hypoxemia

byZoya GomesandMichael Pratte
April 24, 2022
in Emergency, Infectious Disease, Pulmonology
Reading Time: 3 mins read
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Share on FacebookShare on Twitter

1. In this non-randomized controlled trial including 501 patients with COVID-19-associated hypoxemia requiring supplemental oxygen without mechanical ventilation, prone positioning was not found to offer clinical benefits.

2. Prone positioning was found to have an adjusted odds ratio of 1.63 for worse patient outcomes at study day 5 compared to usual care.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Patients with COVID-19 have been shown to develop acute hypoxemic respiratory failure, which in some cases requires invasive mechanical ventilation. A nonpharmacological approach to hypoxemia includes awake prone positioning among patients not receiving mechanical ventilation. This non-randomized controlled trial investigated whether prone positioning was associated with improve clinical outcomes among 501 awake adult patients with COVID-19 hypoxemia requiring supplemental oxygen without mechanical ventilation compared to patients receiving usual care. Patients were assigned to receive either the awake prone positioning intervention or usual care. The primary outcome was the highest level of oxygen support on day 5 according to a WHO COVID-19 ordinal outcome scale. This study found that on day 5, the prone positioning intervention group was more likely to have worse outcomes than usual care (adjusted odds ratio [aOR] = 1.63). Secondary outcomes, such as progression to mechanical ventilation, length of stay and mortality at day 28 did not differ however between groups. The odds of having worsening oxygen requirements among patients receiving the prone position intervention was found to increase from study days 2 through 5. The data from this study suggests that awake prone positioning for patients with COVID-19 associated hypoxemia may worsen clinical outcomes and cause harm. A limitation to this study was that instead of traditional randomization, patients were allocated treatment groups based on medical records. A major strength to this study however that findings of worse outcomes among patients assigned to the intervention group were consistent across multiple post-hoc sensitivity analyses.

Click to read the study in JAMA Internal Medicine

Click to read an accompanying editorial in JAMA Internal Medicine

RELATED REPORTS

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

2 Minute Medicine Rewind August 31, 2026

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

Relevant Reading: Prone positioning in severe acute respiratory distress syndrome

In-Depth [non-randomized controlled trial]: This study investigated whether awake prone positioning was associated with improved outcomes among patients with COVID-19 related hypoxemia who were not receiving mechanical ventilation. A total of 501 patients (mean [SD] age, 61.0 [15.3] years; 284 [56.7%] male), were enrolled from 2 academic medical centers between May 13 to December 11, 2020 during the COVID-19 pandemic. 258 patients were assigned to the prone positioning intervention group and 243 patients were assigned to receive usual care. Upon assessing the WHO ordinal scale on each day, it was found that the odds of being in a worse outcome for oxygen delivery among patients receiving the prone position intervention increased from study days 2 through 5.  On study day 5, the intervention group had a posterior probability of 0.998 for having a worse outcome (posterior median aOR, 1.63, 95% high-density credibility intervention [CrI]. 1.16-2.31). On day 14, the posterior median aOR was 1.29 (95% CrI, 0.84-1.99), and the posterior probability of an aOR of 1.0 of greater was 0.874. Finally, on day 28, the aOR for the posterior median was 1.12 (95% CrI, 0.67-1.86) with a probability of an aOR of 1.0 or greater at 0.673. No evidence of a difference in ventilator-free days or the number of patients progressing to mechanical ventilation during the study (31 patients in the intervention group vs. 30 patients in the usual care group) was detected.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

 

Tags: COVID-19
Previous Post

#VisualAbstract: Odronextamab shows promising clinical activity in patients with relapsed or refractory B-cell non-Hodgkin lymphoma

Next Post

Marginalized identities, mistreatment, discrimination, and burnout among US medical students

RelatedReports

Novel coronavirus identified from patients with pneumonia in Wuhan, China
Emergency

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

September 1, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Weekly Rewinds

2 Minute Medicine Rewind August 31, 2026

August 31, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Hematologic inflammatory indices may predict prognosis in younger patients with COVID-19 but not older patients

August 4, 2026
Elagolix with add-back hormone therapy effective in reducing fibroid-associated menstrual bleeding
Weekly Rewinds

2 Minute Medicine Rewind August 3rd, 2026

August 3, 2026
Next Post
Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse

Marginalized identities, mistreatment, discrimination, and burnout among US medical students

2 Minute Medicine Rewind April 25, 2022

Few older adolescents meet recommended levels of physical activity

Comprehensive laughter-intervention programs as a means to improve physical and psychological health

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Few interventions improve posthospitalization follow-up for alcohol use disorder
  • Borderline-low hemoglobin levels linked to increased mortality
  • 2MM: Pharma Roundup – mRNA flu vaccine debuts, RAS inhibition extends pancreatic cancer survival, and new therapies advance for dermatomyositis and Tourette syndrome
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.